Table 2.
Distribution of companies by clinical robustness score.
| Clinical robustness score | Companies, n (%) |
| 0 | 98 (44) |
| 1 | 34 (15) |
| 2 | 24 (11) |
| 3 | 15 (7) |
| 4 | 8 (4) |
| 5 | 13 (6) |
| 6 | 7 (3) |
| 7 | 4 (2) |
| 8 | 7 (3) |
| 9 | 1 (0) |
| ≥10 | 13 (6) |
Distribution of companies by clinical robustness score.
| Clinical robustness score | Companies, n (%) |
| 0 | 98 (44) |
| 1 | 34 (15) |
| 2 | 24 (11) |
| 3 | 15 (7) |
| 4 | 8 (4) |
| 5 | 13 (6) |
| 6 | 7 (3) |
| 7 | 4 (2) |
| 8 | 7 (3) |
| 9 | 1 (0) |
| ≥10 | 13 (6) |